Localization of mature neprilysin in lipid rafts

Journal of Neuroscience Research

Volumn 90, Issue 4, 2012, Pages 870-877

  Sato, Kimihiko ^a   Tanabe, Chiaki ^b   Yonemura, Yoji ^a   Watahiki, Haruhiko ^a   Zhao, Yimeng ^a   Yagishita, Sosuke ^a   Ebina, Maiko ^a   Suo, Satoshi ^a   Futai, Eugene ^a   Murata, Masayuki ^a   Ishiura, Shoichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Lipid rafts; Neprilysin

Indexed keywords

CHOLESTEROL; GLYCOSYLATED PROTEIN; MEMBRANE METALLOENDOPEPTIDASE; PHOSPHATIDYLSERINE;

ARTICLE; DIMERIZATION; GOLGI COMPLEX; HUMAN; IN VITRO STUDY; LIPID RAFT; PRIORITY JOURNAL; PROTEIN HYDROLYSIS; PROTEIN LOCALIZATION;

AMYLOID BETA-PEPTIDES; BETA-CYCLODEXTRINS; CELL LINE, TRANSFORMED; CHOLESTEROL; DIMERIZATION; ENDOPEPTIDASES; HUMANS; MEMBRANE MICRODOMAINS; MUTATION; NEPRILYSIN; TRANSFECTION;

EID: 84856695882     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22796     Document Type: Article

References (31)

1. Angelisova P, Drbal K, Horejsi V, Cerny J. 1999. Association of CD10/neutral endopeptidase 24.11 with membrane microdomains rich in glycosylphosphatidylinositol-anchored proteins and Lyn kinase. Blood 93: 1437-1439.
2. Bayer TA, Wirths O. 2008. Review on the APP/PS1KI mouse model: intraneuronal Abeta accumulation triggers axonopathy, neuron loss and working memory impairment. Genes Brain Behav 7( Suppl 1): 6-11.
3. Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM. 2005. Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45: 675-688.
4. Cordy JM, Hussain I, Dingwall C, Hooper NM, Turner AJ. 2003. Exclusively targeting beta-secretase to lipid rafts by GPI-anchor addition up-regulates beta-site processing of the amyloid precursor protein. Proc Natl Acad Sci U S A 100: 11735-11740.
5. Fukami S, Watanabe K, Iwata N, Haraoka J, Lu B, Gerard NP, Gerard C, Fraser P, Westaway D, St. George-Hyslop P, Saido TC. 2002. Abeta-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Abeta pathology. Neuroscience research 43: 39-56.
6. Hama E, Shirotani K, Iwata N, Saido TC. 2004. Effects of neprilysin chimeric proteins targeted to subcellular compartments on amyloid beta peptide clearance in primary neurons. J Biol Chem 279: 30259-30264.
7. Hardy JA, Higgins GA. 1992. Alzheimer's disease: the amyloid cascade hypothesis. Science 256: 184-185.
8. Hellstrom-Lindahl E, Ravid R, Nordberg A. 2008. Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels. Neurobiol Aging 29: 210-221.
9. Hoang MV, Sansom CE, Turner AJ. 1997. Mutagenesis of Glu403 to Cys in rabbit neutral endopeptidase-24.11 (neprilysin) creates a disulphide-linked homodimer: analogy with endothelin-converting enzyme. Biochem J 327: 925-929.
10. Iwata N, Tsubuki S, Takaki Y, Shirotani K, Lu B, Gerard NP, Gerard C, Hama E, Lee HJ, Saido TC. 2001. Metabolic regulation of brain Abeta by neprilysin. Science 292: 1550-1552.
11. Iwata N, Takaki Y, Fukami S, Tsubuki S, Saido TC. 2002. Region-specific reduction of A beta-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging. J Neurosci Res 70: 493-500.
12. Iwata N, Mizukami H, Shirotani K, Takaki Y, Muramatsu S, Lu B, Gerard NP, Gerard C, Ozawa K, Saido TC. 2004. Presynaptic localization of neprilysin contributes to efficient clearance of amyloid-beta peptide in mouse brain. J Neurosci 24: 991-998.
13. Kakio A, Nishimoto S, Yanagisawa K, Kozutsumi Y, Matsuzaki K. 2002. Interactions of amyloid beta-protein with various gangliosides in raft-like membranes: importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid. Biochemistry 41: 7385-7390.
14. Kanemitsu H, Tomiyama T, Mori H. 2003. Human neprilysin is capable of degrading amyloid beta peptide not only in the monomeric form but also the pathological oligomeric form. Neurosci Lett 350: 113-116.
15. Kawarabayashi T, Shoji M, Younkin LH, Wen-Lang L, Dickson DW, Murakami T, Matsubara E, Abe K, Ashe KH, Younkin SG. 2004. Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease. J Neurosci 24: 3801-3809.
16. Kenny AJ, Fulcher IS, McGill KA, Kershaw D. 1983. Proteins of the kidney microvillar membrane. Reconstitution of endopeptidase in liposomes shows that it is a short-stalked protein. Biochem J 211: 755-762.
17. Kim J, Basak JM, Holtzman DM. 2009. The role of apolipoprotein E in Alzheimer's disease. Neuron 63: 287-303.
18. Knobloch M, Konietzko U, Krebs DC, Nitsch RM. 2007. Intracellular Abeta and cognitive deficits precede beta-amyloid deposition in transgenic arcAbeta mice. Neurobiol Aging 28: 1297-1306.
19. Kojro E, Gimpl G, Lammich S, Marz W, Fahrenholz F. 2001. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha-secretase ADAM 10. Proc Natl Acad Sci U S A 98: 5815-5820.
20. Lafrance MH, Vezina C, Wang Q, Boileau G, Crine P, Lemay G. 1994. Role of glycosylation in transport and enzymic activity of neutral endopeptidase-24.11. Biochem J 302: 451-454.
21. Lai AY, McLaurin J. 2011. Mechanisms of amyloid-beta peptide uptake by neurons: the role of lipid rafts and lipid raft-associated proteins. Int J Alzheimers Dis 2011: 548380.
22. Matsuzaki K, Noguch T, Wakabayashi M, Ikeda K, Okada T, Ohashi Y, Hoshino M, Naiki H. 2007. Inhibitors of amyloid beta-protein aggregation mediated by GM1-containing raft-like membranes. Biochim Biophys Acta 1768: 122-130.
23. Pike LJ. 2004. Lipid rafts: heterogeneity on the high seas. Biochem J 378: 281-292.
24. Pike LJ. 2006. Rafts defined: a report on the Keystone Symposium on Lipid Rafts and Cell Function. J Lipid Res 47: 1597-1598.
25. Rajendran L, Masilamani M, Solomon S, Tikkanen R, Stuermer CA, Plattner H, Illges H. 2003. Asymmetric localization of flotillins/reggies in preassembled platforms confers inherent polarity to hematopoietic cells. Proc Natl Acad Sci U S A 100: 8241-8246.
26. Riemann D, Hansen GH, Niels-Christiansen L, Thorsen E, Immerdal L, Santos AN, Kehlen A, Langner J, Danielsen EM. 2001. Caveolae/lipid rafts in fibroblast-like synoviocytes: ectopeptidase-rich membrane microdomains. Biochem J 354: 47-55.
27. Selkoe DJ. 2002. Alzheimer's disease is a synaptic failure. Science 298: 789-791.
28. Suzuki S, Kiyosue K, Hazama S, Ogura A, Kashihara M, Hara T, Koshimizu H, Kojima M. 2007. Brain-derived neurotrophic factor regulates cholesterol metabolism for synapse development. J Neurosci 27: 6417-6427.
29. von Tresckow B, Kallen KJ, von Strandmann EP, Borchmann P, Lange H, Engert A, Hansen HP. 2004. Depletion of cellular cholesterol and lipid rafts increases shedding of CD30. J Immunol 172: 4324-4331.
30. Wada S, Morishima-Kawashima M, Qi Y, Misono H, Shimada Y, Ohno-Iwashita Y, Ihara Y. 2003. Gamma-secretase activity is present in rafts but is not cholesterol-dependent. Biochemistry 42: 13977-13986.
31. Yang DS, Stavrides P, Mohan PS, Kaushik S, Kumar A, Ohno M, Schmidt SD, Wesson D, Bandyopadhyay U, Jiang Y, Pawlik M, Peterhoff CM, Yang AJ, Wilson DA, St. George-Hyslop P, Westaway D, Mathews PM, Levy E, Cuervo AM, Nixon RA. 2011. Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits. Brain 134: 258-277.